Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced Breast Cancer × sacituzumab govitecan × Clear all

Phase

Status

Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Non-Small-Cell Lung 3 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Urothelial Bladder Carcinoma 1 Solid Tumor 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Brain Neoplasms 1 Advanced Breast Cancer 1

Interventions

sacituzumab govitecan 1 Safety 1 Letrozole 1 Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06612203 2025-12-05

WIN-B

MedSIR

Phase 1/2 Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡